Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies

Condition:   Centronuclear Myopathy Intervention:   Drug: DYN101 Sponsor:   Dynacure SAS Not yet recruiting

Source: ClinicalTrials.gov - July 25, 2019 Category: Research Source Type: clinical trials